ClinicalTrials.Veeva

Menu

Zinc Supplementation and Severe and Recurrent Diarrhea

H

Hormozgan University of Medical Sciences

Status

Completed

Conditions

Diarrhea

Treatments

Drug: Zinc Supplement

Study type

Interventional

Funder types

Other

Identifiers

NCT01306097
Zinc supplementation

Details and patient eligibility

About

Evaluating the impact of 3 months daily zinc supplementation on incidence of severe and recurrent diarrhea in 6 to 36 months age children in Bandarabbaas

Full description

Evaluating the impact of 3 months daily zinc supplementation on incidence of severe and recurrent diarrhea in 6 to 36 months age children in Bandarabbaas in 2009

Enrollment

100 patients

Sex

All

Ages

6 to 36 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All 6 to 36 months old children without diarrhea at the time of study and without disease such as celiac
  • Inflammatory bowl disease and hypersensitivity to milk

Exclusion criteria

  • Diarrhea at the time of the study and background disease such as celiac, IBD or hypersensitivity to milk

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 1 patient group

Zinc sulfate
Experimental group
Description:
daily zinc supplementation for 3 months. (10mg daily for under 1 years old children and 20mg daily for above 1 years old children)
Treatment:
Drug: Zinc Supplement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems